Dechra Pharmaceuticals Share Price (DPH)

1,335.00 +7.00 (+0.53%) delayed: 1:11AM BST
Bid price 1,333.00 Open price 1,317.00
Ask price 1,335.00 Prev close 1,335.00
High price 1,347.00 Spread 0.15%
Low price 1,317.00 Volume 78,954

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 1,335.00 Net Gearing (%) 17.70
Market Capitalisation (£m) 1,231.13 Gross Gearing (%) 33.42
Shares in issue (m) 92.71 Debt Ratio 21.58
P/E Ratio 59.98 Debt-to-Equity Ratio 0.55
Total dividends per share (p) 16.94 Assets / Equity Ratio 1.50
Dividend Yield (%) 1.31 Price to book value 6.33
Dividend cover (x) 1.25 ROCE (%) 10.41
Earning per share (p) 22.14 EPS Growth (%) -67.23
52 week high / low 1,423.00 / 811.00 DPS Growth (%) 10.00

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
06/06/2016 BUY Tony Rice NED 20,000
18/03/2016 EXR Ian Page CEO 87,905
18/03/2016 SEXR Ian Page CEO 41,440
18/03/2016 EXR Tony Griffin ED 32,027
09/09/2015 EXR Anne-Françoise Nesmes RES 38,859

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

09:31 17/08/2016

Dechra appoints CFO

Dechra Pharmaceuticals has appointed Richard Cotton as chief financial officer following the resignation of Anne-Francoise Nesmes which was announced in February. Cotton will join the company once he has served the notice period in his current role as CFO of Consort Medical, which is expected...

07:30 17/08/2016

Directorate Change

/* */ RNS Number : 3280H Dechra Pharmaceuticals PLC 17 August 2016     17 August 2016   Dechra ® Pharmaceuticals PLC (Dechra, Company or the Group) Board Changes   Appointment of Chief Financial Officer Further to the...

13:33 04/08/2016

Holding(s) in Company

/* */ RNS Number : 2976G Dechra Pharmaceuticals PLC 04 August 2016               TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i     1. Identity...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions